AI in Medical Writing Market Size, Share & Industry Analysis, By Component (Software and Services), By Technology (Machine Learning & Deep Learning, Natural Language Processing, and Others), By Deployment (Cloud-Based, On Premise, and Hybrid), By Therapeutic Area (Oncology, Central Nervous System, Infectious Diseases, Rare Diseases, Immunology, Cardio-metabolic, and Others), By Application (Regulatory writing, Clinical writing, Scientific Publications & Medical Communications, Safety/Pharmacovigilance Writing, & Others), By End User, and Regional Forecast, 2026-2034

Last Updated: April 03, 2026 | Format: PDF | Report ID: FBI115858

To get information on various segments, share your queries with us

ATTRIBUTE	DETAILS
Study Period	2021-2034
Base Year	2025
Estimated Year	2026
Forecast Period	2026-2034
Historical Period	2021-2024
Growth Rate	CAGR of 24.99% from 2026 to 2034
Unit	Value (USD Billion)
Segmentation	By Component, Technology, Deployment, Therapeutic Area, Application, End User, and Region
By Component	Software Services Managed services / human-in-loop
By Technology	Machine Learning & Deep Learning Natural Language Processing Others
By Deployment	Cloud-based On-premise Hybrid
By Therapeutic Area	Oncology Central Nervous System Infectious Diseases Rare Diseases Immunology Cardiometabolic Others
By Application	Regulatory Writing Clinical Writing Scientific Publications & Medical Communications Safety/Pharmacovigilance Writing Medical Information/Response Letters HEOR/Grants/Market Access Writing Others
By End User	CROs & CDMOs Medtech/Pharma Companies Med Comms Agencies Academic/Research Institutes Others
By Region	North America (By Component, Technology, Deployment, Therapeutic Area, Application, End User, and Country) U.S. Canada Europe (By Component, Technology, Deployment, Therapeutic Area, Application, End User, and Country/Sub-region) Germany U.K. France Spain Italy Scandinavia Rest of Europe Asia Pacific (By Component, Technology, Deployment, Therapeutic Area, Application, End User, and Country/Sub-region) China Japan India Australia Southeast Asia Rest of Asia Pacific Latin America (By Component, Technology, Deployment, Therapeutic Area, Application, End User, and Country/Sub-region) Brazil Mexico Rest of Latin America Middle East & Africa (By Component, Technology, Deployment, Therapeutic Area, Application, End User, and Country/Sub-region) GCC South Africa Rest of Middle East & Africa